Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 582 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is L  [Clear All Filters]
2002
Hu X, Herrero C, Li W-P, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, G Haines K, Ivashkiv LB.  2002.  Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation.. Nat Immunol. 3(9):859-66.
2001
Peng Y, Mian IS, Lue NF.  2001.  Analysis of telomerase processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance.. Mol Cell. 7(6):1201-11.
Schwer B, Lehman K, Saha N, Shuman S.  2001.  Characterization of the mRNA capping apparatus of Candida albicans.. J Biol Chem. 276(3):1857-64.
Bosoy D, Lue NF.  2001.  Functional analysis of conserved residues in the putative "finger" domain of telomerase reverse transcriptase.. J Biol Chem. 276(49):46305-12.
Chitale S, Ehrt S, Kawamura I, Fujimura T, Shimono N, Anand N, Lu S, Cohen-Gould L, Riley LW.  2001.  Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry.. Cell Microbiol. 3(4):247-54.
Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK.  2001.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.. Proc Natl Acad Sci U S A. 98(13):7534-9.
2000
Niu H, Xia J, Lue NF.  2000.  Characterization of the interaction between the nuclease and reverse transcriptase activity of the yeast telomerase complex.. Mol Cell Biol. 20(18):6806-15.
Xia J, Peng Y, Mian IS, Lue NF.  2000.  Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase.. Mol Cell Biol. 20(14):5196-207.
1999
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS.  1999.  Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.. J Biol Chem. 274(12):7674-80.
Lue NF.  1999.  Sequence-specific and conformation-dependent binding of yeast telomerase RNA to single-stranded telomeric DNA.. Nucleic Acids Res. 27(12):2560-7.
1998
Lue NF, Peng Y.  1998.  Negative regulation of yeast telomerase activity through an interaction with an upstream region of the DNA primer.. Nucleic Acids Res. 26(6):1487-94.
Lue NF, Xia J.  1998.  Species-specific and sequence-specific recognition of the dG-rich strand of telomeres by yeast telomerase.. Nucleic Acids Res. 26(6):1495-502.
Kapitskaya MZ, Dittmer NT, Deitsch KW, Cho WL, Taylor DG, Leff T, Raikhel AS.  1998.  Three isoforms of a hepatocyte nuclear factor-4 transcription factor with tissue- and stage-specific expression in the adult mosquito.. J Biol Chem. 273(45):29801-10.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
1997
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Lue NF, Peng Y.  1997.  Identification and characterization of a telomerase activity from Schizosaccharomyces pombe.. Nucleic Acids Res. 25(21):4331-7.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan C.  1997.  Identification of nitric oxide synthase as a protective locus against tuberculosis.. Proc Natl Acad Sci U S A. 94(10):5243-8.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.
Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG et al..  1997.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.. Proc Natl Acad Sci U S A. 94(18):9814-9.
1996
Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E.  1996.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.. J Virol. 70(4):2116-23.